Q2 2019 Holdings
Filed 2019-08-14 | 37 holdings | $140.9M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2019-08-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $111.6M | 900,000 | 79.2% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $28.3M | 200,000 | 20.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $176.7K | 1,715,560 | 0.1% |
| Odonate Therapeutics Inc | COM | 676079106 | $123.4K | 3,363,377 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $91.1K | 6,567,000 | 0.1% |
| Spark Therapeutics Inc | COM | 84652J103 | $61.4K | 600,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $48.1K | 615,400 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $45.4K | 975,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $45.0K | 1,000,000 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $43.6K | 5,300,000 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $41.6K | 1,875,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $32.7K | 1,733,583 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $29.9K | 1,102,194 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $29.0K | 2,325,000 | 0.0% |
| Medicines Co | COM | 584688105 | $27.4K | 750,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $26.1K | 1,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $22.0K | 1,466,051 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $20.6K | 475,000 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $20.0K | 3,473,272 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $16.6K | 844,789 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $14.8K | 1,123,105 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $13.2K | 250,000 | 0.0% |
| Esperion Therapeutics Inc NECallA | CALL | 29664W905 | $11.6K | 250,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $9.0K | 1,250,000 | 0.0% |
| Matinas Biopharma Hldgs Inc | COM | 576810105 | $8.7K | 10,188,312 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $8.4K | 2,084,000 | 0.0% |
| Immunomedics IncCallA | CALL | 452907908 | $8.3K | 600,000 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $7.6K | 764,252 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $7.6K | 396,695 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $7.6K | 3,688,100 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $7.3K | 2,913,091 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $5.3K | 575,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.4K | 200,000 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $3.9K | 290,577 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $2.7K | 100,000 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $2.0K | 920,000 | 0.0% |
| Novus Therapeutics Inc | COM | 67011N105 | $328 | 324,383 | 0.0% |